Diagnosis and treatment strategies for atlantoaxial dislocation
A Study on Diagnosis and Treatment Strategies for Atlantoaxial Dislocation
This study looks at how to better diagnose and treat people with atlantoaxial dislocation using different surgical methods based on the severity of their condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Sex | All |
| Sponsor | Peking University Third Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT06233539 on ClinicalTrials.gov |
What this trial studies
This study focuses on the diagnosis and treatment strategies for patients with atlantoaxial dislocation, primarily through surgical approaches. It analyzes a comprehensive dataset of 904 cases from 1998 to 2010 to refine treatment protocols based on the severity of the dislocation. The classification includes unstable, reversible, difficult to recover, and skeletal types, guiding the surgical treatment process. The study aims to update and improve existing diagnostic and treatment methodologies based on accumulated clinical experience and advancements in surgical techniques.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with atlantoaxial dislocation who are undergoing surgical treatment.
Not a fit: Patients who do not agree to participate in the study will not benefit from its findings.
Why it matters
Potential benefit: If successful, this study could enhance surgical outcomes and recovery for patients with atlantoaxial dislocation.
How similar studies have performed: Other studies have shown success in refining surgical approaches for atlantoaxial dislocation, making this study a continuation of established research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with atlantoaxial dislocation and treated with surgery Exclusion Criteria: * Disagree to participate in this study.
Where this trial is running
Beijing, Beijing Municipality
- Shenglin Wang — Beijing, Beijing Municipality, China (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.